|
Treatment for Anxiety in Children Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Treatment for Anxiety in Children conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Treatment for Anxiety in Children Clinical research trials and Treatment for Anxiety in Children health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Treatment for Anxiety in Children. Treatment for Anxiety in Children Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Treatment for Anxiety in Children clinical trial. Human subjects often get the best healthcare possible for their Treatment for Anxiety in Children condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment for Anxiety in Children  Treatment for Anxiety in Children
Treatment for Anxiety in Children
For Condition: Obsessive-Compulsive Disorder,Anxiety Disorders,Generalized Anxiety Disorder,Social Phobia,Separation Anxiety
Status: Completed
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to see if it is effective to treat children with anxiety disorders with fluvoxamine. Fluvoxamine has been successfully used to treat obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD, such as generalized anxiety disorder, social phobia, or separation anxiety, are very common in youth and are not always responsive to behavioral therapies alone. These disorders may respond to fluvoxamine. A child will be evaluated for 3 weeks before he/she is assigned randomly (like tossing a coin) to receive either fluvoxamine or an inactive placebo for 8 weeks. After this double-blind phase (neither the child/parents nor the doctor know which treatment is being given), the child will have the option of continuing treatment during a 4-month open-label extension period (both the child/parents and the doctor know which the child is receiving). A child may be eligible for this study if he/she: Is 6 to 17 years old and has been diagnosed with an anxiety disorder (i.e., generalized anxiety disorder, social phobia, or separation anxiety).
Details: To evaluate fluvoxamine in the treatment of children and adolescents with anxiety disorders. Fluvoxamine is a serotonin reuptake inhibitor that is FDA-approved for the treatment of obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD are very common in youth and are not always responsive to psychosocial therapies. Fluvoxamine is an alternative treatment. After a 3-week period of evaluation, patients meeting study entry criteria are randomized to receive either fluvoxamine or placebo for 8 weeks. After this double-blind phase, patients can enter a 4-month open-label extension.
Eligibility:
Study Type: Interventional, Treatment, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 6 Years/17 Years
Genders: Both
Protocol Entry Criteria: - Patients must have: DSM -IV diagnosis of generalized anxiety disorder, social phobia, or separation anxiety.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
LaurenceGreenhill, Principal Investigator,
Additional Information:
Study ID Numbers: MH60005; MH60016
Study Start Date: October 1996
Record last reviewed: April 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000389
Other Separation Anxiety Studies:
1. Treatment for Anxiety in Children
2. Treatment of Youth with ADHD and Anxiety
3. Treatment of Social Phobia
Related Studies:
Other Separation Anxiety Clinical Trials
Other Clinical Trials
Other Clinical Trials
Treatment for Anxiety in Children
|
|
|
|
|
|
|
|
